MANY MINDEDAyana Bio Secures Meati Foods Assets for Scalable Plant Cell Culture in India
Ayana Bio and Zenfold Sustainable Technologies jointly acquired Meati Foods' 300,000-liter fermentation capacity for $75,000 in July 2026. This move follows Meati Foods' financial distress: the company entered Assignment for the Benefit of Creditors (ABC) in May 2025, was acquired by Meati Holdings before year-end 2025 layoffs, and had 12x 25,000-liter fermentation tanks valued at 'several million dollars.' Crucially, the assets were not sold at Meati Foods' scheduled spring 2026 auction, leaving core fermentation equipment available for reuse. Ayana Bio and Zenfold now plan to establish a dedicated plant cell culture pilot facility in India using this equipment, targeting operational readiness by early 2027.
The substance lies in repurposing Meati Foods' underutilized infrastructure for scalable production. While Ayana Bio's first commercial product is rosmarinic acid derived from sage, the acquisition targets plant cell culture technology that could eventually produce meat alternatives. This avoids the cost of new equipment while leveraging existing capacity—a critical step for reducing the capital barriers to lab-grown food.
This advance moves food abundance by potentially lowering costs for scalable plant-based proteins in India. If the pilot facility achieves its timeline, it could expand access to affordable lab-grown foods without requiring new fermentation infrastructure. However, the current focus remains on rosmarinic acid, not meat, so broader food cost reductions depend on future scaling.
What to watch: Ayana Bio's 2027 operational readiness, challenges in transitioning from rosmarinic acid production to meat alternatives, and whether the 'several million dollars' equipment value impacts scalability. The source notes Meati Foods' assets were not sold at auction but core fermentation capacity remained available—a key detail for assessing real-world progress.
Source: AgFunder News